Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$6,971,516
+$1,743,572 QoQ
Shares Held
382,840
+4.1% QoQ
Ownership
0.595%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 3% Shared 0% None 97%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. CGEM ranks #52 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,971,516 382,840
2026-03-31 $5,227,944 367,906
2025-12-31 $6,071,682 586,636
2025-09-30 $3,390,406 571,738
2025-06-30 $4,267,860 566,781
2025-03-31 $4,356,768 575,531
2024-12-31 $7,066,055 580,136
2024-09-30 $9,389,013 560,873
2024-06-30 $9,680,368 555,067
2024-03-31 $9,359,663 549,276
2023-12-31 $5,559,500 545,584
2023-09-30 $41,783 4,617
2023-06-30 $89,232 8,293
2023-03-31 $163,300 15,963
2022-12-31 $129,859 12,309
2022-09-30 $155,186 12,105
2022-06-30 $180,736 14,098
2022-03-31 $150,369 14,362
2021-12-31 $247,250 16,024
2021-09-30 $343,108 15,202
2021-06-30 $214,239 8,320
2021-03-31 $357,611 8,582